ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Vizient Hosts Congressional Briefing on Pressures Facing Hospitals

Yesterday on Capitol Hill, Vizient, Inc. hosted a policy briefing titled, “Provider Pressures Persist: Hospitals' Struggles Against Financial, Workforce and Supply Chain Strains” at the Rayburn House Office Building in Washington, D.C. Attended by more than 50 Congressional staff and other healthcare stakeholders, this briefing focused on how hospitals are responding to mounting pressures while continuing to provide essential community benefits.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230307005370/en/

From left: Raghu Adiga, Peter Newcomer, Allison Rogers, Jack Lynch III and Margaret Steele at the Vizient-hosted 2023 policy briefing entitled, "Provider Pressures Persist: Hospitals' Struggles Against Financial, Workforce and Supply Chain Strains” at the Rayburn House Office Building in Washington, D.C. March 6, 2023. (Photo: Business Wire)

From left: Raghu Adiga, Peter Newcomer, Allison Rogers, Jack Lynch III and Margaret Steele at the Vizient-hosted 2023 policy briefing entitled, "Provider Pressures Persist: Hospitals' Struggles Against Financial, Workforce and Supply Chain Strains” at the Rayburn House Office Building in Washington, D.C. March 6, 2023. (Photo: Business Wire)

“Hospitals have faced some of the most difficult challenges in history over the last couple of years, and despite federal efforts, they continue to grapple with severe financial obstacles driven by inflation and ongoing workforce issues,” said Margaret Steele, senior vice president, Med/Surg, GPO Services & Delivery for Vizient. “It is imperative that we understand the threats facing hospitals and what they anticipate in the path ahead as they remain deeply committed to meeting the needs of patients.”

Steele moderated the policy discussion with an esteemed panel of key hospital leaders including:

  • Dr. Raghu Adiga, MD, President & Chief Executive Officer, Liberty Hospital
  • Jack Lynch III, FACHE, President & Chief Executive Officer, Main Line Health
  • Dr. Peter Newcomer, MD, MMM, Senior Vice President & Chief Clinical Officer, UW Health
  • Allison Rogers, Chief Strategy Officer, Ballad Health

The panel of experts outlined the myriad shared risks their hospitals are facing, including decreased reimbursements from payers, inflationary pressures and persistent workforce shortages. Despite these challenges, these providers, and others, are committed to patient care and delivering critical community benefits. The panelists highlighted their focus on enhancing primary care access, providing clinical education, initiatives to support maternal health and reduce health disparities, and supporting patient access to care through hospital-at-home programs and rural healthcare facility investments.

Vizient looks forward to continuing to partner alongside policymakers and our provider members to help hospitals overcome challenges associated with rising costs and the evolving healthcare delivery landscape in the aftermath of the COVID-19 pandemic.

About Vizient, Inc.

Vizient, Inc., the nation’s largest health care performance improvement company, serves more than 50% of the nation’s acute care providers, which includes 97% of the nation’s academic medical centers, and more than 25% of the non-acute market. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $130 billion in annual purchasing volume. Vizient’s solutions and services improve the delivery of high-value care by aligning cost, quality and market performance. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.